280 related articles for article (PubMed ID: 28092205)
1. Effect of polidocanol foam administration into rat peripheral veins on pulmonary parenchyma.
de Moraes Silva MA; Ferreira RG; de Jesus-Silva SG; Cardoso RS; Miranda F
Phlebology; 2018 Mar; 33(2):122-127. PubMed ID: 28092205
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.
King JT; O'Byrne M; Vasquez M; Wright D;
Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639
[TBL] [Abstract][Full Text] [Related]
3. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
Rabe E; Otto J; Schliephake D; Pannier F
Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
[TBL] [Abstract][Full Text] [Related]
5. Venous disorders: treatment with sclerosant foam.
Bergan J; Pascarella L; Mekenas L
J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941
[TBL] [Abstract][Full Text] [Related]
6. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
Hamel-Desnos C; Desnos P; Wollmann JC; Ouvry P; Mako S; Allaert FA
Dermatol Surg; 2003 Dec; 29(12):1170-5; discussion 1175. PubMed ID: 14725657
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-guided catheter-directed foam sclerotherapy for great saphenous vein.
Kurdal AT; Yildirim F; Ozbakkaloglu A; Iskesen I; Tetik O
Minerva Chir; 2015 Feb; 70(1):33-6. PubMed ID: 25650651
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-guided sclerotherapy of the great saphenous vein with 1% vs. 3% polidocanol foam: a multicentre double-blind randomised trial with 3-year follow-up.
Blaise S; Bosson JL; Diamand JM
Eur J Vasc Endovasc Surg; 2010 Jun; 39(6):779-86. PubMed ID: 20206556
[TBL] [Abstract][Full Text] [Related]
10. Catheter-directed foam sclerotherapy of axial saphenous reflux: early results.
Kölbel T; Hinchliffe RJ; Lindblad B
Phlebology; 2007; 22(5):219-22. PubMed ID: 18269073
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a 2-year follow-up.
Ouvry P; Allaert FA; Desnos P; Hamel-Desnos C
Eur J Vasc Endovasc Surg; 2008 Sep; 36(3):366-70. PubMed ID: 18524643
[TBL] [Abstract][Full Text] [Related]
12. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
Todd KL; Wright DI;
Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
[TBL] [Abstract][Full Text] [Related]
13. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.
Ukritmanoroat T
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S35-40. PubMed ID: 21717876
[TBL] [Abstract][Full Text] [Related]
14. Sclerotherapy and foam sclerotherapy for varicose veins.
Coleridge Smith P
Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
[TBL] [Abstract][Full Text] [Related]
15. Polidocanol for endovenous microfoam sclerosant therapy.
Eckmann DM
Expert Opin Investig Drugs; 2009 Dec; 18(12):1919-27. PubMed ID: 19912070
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence.
Gibson K; Kabnick L;
Phlebology; 2017 Apr; 32(3):185-193. PubMed ID: 27013511
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency.
Yamaki T; Nozaki M; Iwasaka S
Dermatol Surg; 2004 May; 30(5):718-22; discussion 722. PubMed ID: 15099313
[TBL] [Abstract][Full Text] [Related]
18. Results of Ultrasound-Guided Foam Sclerotherapy of the Great Saphenous Vein With New Parameters of the Technique.
Baeshko A; Shestak N; Korytko S
Vasc Endovascular Surg; 2016 Nov; 50(8):528-533. PubMed ID: 27837181
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results of severe venous insufficiency treatment with thermal ablation of the great saphenous vein by endovascular technique with laser diode 980nm developed in Brazil, associated with sclerotherapy with polidocanol.
Bertanha M; Sobreira ML; Camargo PAB; Pimenta REF; Mariúba JVO; Moura R; Bagnato VS; Yoshida WB
Rev Col Bras Cir; 2017; 44(3):308-313. PubMed ID: 28767808
[TBL] [Abstract][Full Text] [Related]
20. Technical feasibility and early results of radiologically guided foam sclerotherapy for treatment of varicose veins.
Li L; Hong XY; Zeng XQ; Luo PL; Yi Q
Dermatol Surg; 2011 Jul; 37(7):992-8. PubMed ID: 21585599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
